"Established by the Franciscan Sisters of the Poor in 1867, Saint Michael's Medical Center is a 358-bed regional tertiary-care, teaching, and research center in the heart of Newark's business and educational district and is accredited by The Joint Commission."

During the past decade, Saint Michael's Medical Center conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 34 clinical trials were completed, i.e. on average, 117.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Michael's Medical Center" #1 sponsor was "Gilead Sciences" with 30 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials sponsored, "Saint Michael's Medical Center" with 6 trials sponsored, "Abbott" with 4 trials sponsored and "Boston Scientific Corporation" with 4 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Michael's Medical Center" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Saint Michael's Medical Center" are "HIV Infections" (35 trials), "HIV-1 Infection" (10 trials), "HIV" (8 trials), "HIV Infection" (5 trials) and "Acquired Immunodeficiency Syndrome" (4 trials). Many other conditions were trialed in "Saint Michael's Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Michael's Medical Center" are "Drug" (75 trials), "Device" (12 trials), "Other" (7 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "FTC/TDF" (8 trials), "RTV" (6 trials), "ATV" (5 trials) and "E/C/F/TAF" (5 trials). Other intervention names were less common.

The vast majority of trials in "Saint Michael's Medical Center" are 93 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Michael's Medical Center". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 68 completed trials in Saint Michael's Medical Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Michael's Medical Center, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 11 trials that are defined as “Not Applicable".

Saint Michael's Medical Center has several departments that took part in Clinical trials: "Saint Michaels Medical Center - Infectious Disease" - 6 trials